Interpace Biosciences Inc (IDXG)
3.28
+0.29
(+9.70%)
USD |
OTCM |
Nov 13, 16:00
Interpace Biosciences Debt to Equity Ratio: -0.1149 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.1149 |
| March 31, 2024 | -0.1446 |
| December 31, 2023 | -0.1515 |
| September 30, 2023 | -0.1845 |
| June 30, 2023 | -0.2059 |
| March 31, 2023 | -0.2132 |
| December 31, 2022 | -0.2167 |
| September 30, 2022 | -0.2028 |
| June 30, 2022 | -0.2561 |
| March 31, 2022 | -0.2331 |
| December 31, 2021 | -0.2226 |
| September 30, 2021 | -0.2037 |
| June 30, 2021 | -0.2157 |
| March 31, 2021 | -0.1548 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 2.008 |
| March 31, 2020 | 0.1755 |
| December 31, 2019 | 0.1383 |
| September 30, 2019 | 0.1589 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.1776 |
| December 31, 2016 | 1.211 |
| September 30, 2016 | -6.101 |
| June 30, 2016 | 1.47 |
| March 31, 2016 | 1.035 |
| December 31, 2015 | 0.644 |
| September 30, 2015 | 4.762 |
| June 30, 2015 | 2.689 |
| March 31, 2015 | 1.645 |
| December 31, 2014 | 1.350 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.2561
Minimum
Jun 2022
2.008
Maximum
Jun 2020
-0.0209
Average
-0.1845
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0007 |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 0.3083 |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.97M |
| Total Liabilities (Quarterly) | 72.00M |
| Shareholders Equity (Quarterly) | -59.03M |
| Current Ratio | 0.5342 |
| Net Debt Paydown Yield | 26.02% |